Mitochondrial pathology muscle dopaminergic neuron degeneration caused inactivation Drosophila Pink1 rescued Parkin
Yufeng Yang*â€ , Stephan Gehrke*â€ , Yuzuru Imai*â€ , Zhinong Huang*â€ , Yingshi Ouyang*â€ , Ji-Wu Wang*â€ , Lichuan Yangâ€¡,
M. Flint Bealâ€¡, Hannes Vogel*, Bingwei Lu*â€ Â§
*Department Pathology â€ Geriatric Research, Education Clinical Centerå…¾Veterans Affairs Palo Alto Health Care  Stanford University School Medicine, Palo Alto, CA 94304; â€¡Department Neurology, Cornell University Medical College, 525 East 68th Street, New York, NY 10021

Edited Susan L. Lindquist, Whitehead Institute Biomedical Research, Cambridge, MA, approved June 1, 2006 (received review March 28, 2006)

Mutations Pink1, gene encoding Serå…¾Thr kinase                    mitochondrial localization Pink1 protein shown using
mitochondrial-targeting signal, associated Parkinsonâ€™s                transfected cells (8, 25, 26). vitro biochemical studies disease (PD), common movement disorder characterized                  demonstrated Pink1 possesses autophosphorylation activity selective loss dopaminergic neurons. mechanism                    pathogenic mutations Pink1 differential effects loss Pink1 leads neurodegeneration understood.              activity (25, 26). vivo substrate(s) molecular function inhibition Drosophila Pink1 (dPink1) function             Pink1 unknown. Cell culture studies shown results energy depletion, shortened lifespan, degeneration              overexpression wild-type Pink1 lead reduction of select indirect flight muscles dopaminergic neurons.                cytochrome c release mitochondria prevent subse-
muscle pathology preceded mitochondrial enlargement                     quent activation caspases basal apoptotic stress




                                                                                                                                                                            NEUROSCIENCE disintegration. phenotypes rescued wild              conditions (27). result suggests Pink1 play critical
type pathogenic C-terminal deleted form human
                                                                               role regulating mitochondrial physiology andå…¾or mitochon-
Pink1 (hPink1). muscle dopaminergic phenotypes associ-
                                                                               drial pathway cell death, vivo relevance ated dPink1 inactivation similarity seen parkin
                                                                               findings remains determined.
mutant flies suppressed overexpression                                                                                   understand physiological function Pink1 Parkin DJ-1. Consistent genetic rescue results,  dPink1 RNA interference (RNAi) animals, level                                                                                dysfunction cause PD, used Drosophila model
Parkin protein significantly reduced.  results
                                                                                 phenotypes caused inactivation implicate Pink1 Parkin common pathway regulates                  Drosophila Pink1 (dPink1). results indicate dPink1 mitochondrial physiology cell survival Drosophila.                      required maintaining proper mitochondria morphology                                                                                integrity subsets muscle cells dopaminergic neurons.
mitochondria å…© Parkinsonâ€™s disease å…© Pten-induced kinase 1 å…©                   Significantly, Pink1 Parkin clear genetic indirect flight muscle                                                         biochemical interactions. results suggest Parkin Pink1
                                                                               function common molecular pathway regulates mitochon-
                                                                               dria function survival selective cell types.
P    arkinsonâ€™s disease (PD) common movement disor-
     der characterized pathologically deficiency brain
dopamine content selective degeneration dopaminergic
                                                                               Results
neurons substantia nigra. common forms PD               Knocking dPink1 Expression Transgenic RNAi. sporadic known cause.  postmortem studies                 sequenced fly genome, homologue human Pink1 identified common features associated sporadic PD,              (hPink1) dPink1. dPink1 hPink1 share â¬‡26  mitochondrial complex dysfunction, oxidative stress, ag-              identity amino acid level, homology quite low gregation abnormal proteins (1, 2).                                         DNA level, sequence homology prediction algo-
   initial studies etiology PD focused              rithms failed detect significant homology  Based
environmental factors, recent genetic studies firmly estab-               fact loss function hPink1 associated familial
lished contribution inheritable factors PD pathogenesis (2,          PD, used transgenic RNAi approach knockdown 3). distinct loci associated rare familial         expression dPink1 effort model Pink1-associated PD. forms PD (FPD). anticipated understanding                    confirm expression dPink1 dsRNA resulted 
molecular lesions associated FPD genes shed light           regulation endogenous dPink1 transcripts, used RT-PCR pathogenesis common forms disease.                      measure dPink1 mRNA levels ubiquitous induction RNAi.
Dominant mutations â?£-Synuclein (â?£-Syn) LRRK2å…¾dardarin                   â¬‡80  reduction dPink1 mRNA observed (Fig. 1A). recessive mutations parkin, DJ-1, Pink1                   assayed effect RNAi endogenous dPink1 protein
associated FPD (4â€“10). genes, â?£-Syn, parkin,            expression using polyclonal antibody raised dPink1. DJ-1 intensively studied. Studies using vivo                 shown Fig. 1B, ubiquitous dPink1 RNAi resulted similar
animal models vitro cell culture linked mutations               degree reduction endogenous dPink1 protein level. Taken  genes impairments mitochondrial structure function             gether, results demonstrated RNAi approach oxidative stress response, reinforcing general involvement mitochondrial dysfunction oxidative stress PD pathogen-
esis (11â€“21). Consistent notion, proteins            Conflict statement: conflicts declared.
shown present mitochondria interact mitochondrial             paper submitted directly (Track II) PNAS office.
proteins (8, 22â€“24), suggesting directly regulate                Abbreviations: DA, dopamine; dPink1, Drosophila Pink1; hPink1, human Pink1; dParkin,
mitochondria function.                                                         Drosophila Parkin; hParkin, human Parkin; IFM, indirect flight muscle; PD, Parkinsonâ€™s
   link mitochondria PD supported                 disease; RNAi, RNA interference; TH, tyrosine hydroxylase; TTM, tergotrochanteral muscles. fact Pink1 encodes predicted Serå…¾Thr kinase                     correspondence addressed. E-mail: bingwei@stanford.edu.
Ca2â«¹å…¾calmodulin family localized mitochondria (8).                  Â© 2006 National Academy Sciences USA



www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0602493103                                                      PNAS å…© July 11, 2006 å…© vol. 103 å…©  28 å…© 10793â€“10798
 Fig. 1. Inhibition dPink1 RNAi causes defects abnormal wing posture, shortened lifespan, ATP deficit.  B) RT-PCR Western blot analyses dPink1 mRNA protein levels RNAi. Genotypes: 1, Da-Gal4å…¾â«¹; 2, Da-Gal4â¬ŽdPink1 RNAi. RP49 tubulin serve controls. (Câ€“E) Wing posture
phenotypes control dPink1 RNAi flies. Left, females; right, males. Flies 7 days old kept 29Â°C. (C) Straight wing posture control flies. (D) dPink1
RNAi flies displaying held wings. (E) dPink1 RNAi flies displaying drooped wings. (F) Abolished flight activities dPink1 RNAi flies. independent lines used. (G) dPink1 RNAi flies exhibit sharper age-dependent decline ATP content. (H) Female dPink1 flies exhibit shortened lifespan.  H) RNAi achieved using UAS-dPink1 RNAi construct driven Da-Gal4. *, P â¬? 0.01 Studentâ€™s t test.



effective causing significant reduction dPink1 mRNA                         displayed â¬‡70  reduction overall ATP level compared protein expression.                                                                   control flies (Fig. 6, published supporting information
                                                                                      PNAS web site). test ATP deficit Ubiquitous Inhibition dPink1 Results Abnormal Wing Posture,                     age-dependent, took advantage fact level Energy Depletion, Shortened Lifespan. analyzed                        transgene expression temperature-dependent UAS-Gal4
physiological consequence inhibiting dPink1 function.                      raised flies 18Â°C eclosion minimize RNAi
used daughterless (Da)-Gal4 drive expression dPink1                         effect shifted 29Â°C immediately eclosion dsRNA ubiquitously. emergence adult flies ubiquitous                     induce stronger RNAi effect. HPLC analysis clearly demon-
inhibition dPink1 suggested loss dPink1 lead                 strated  ATP level newly eclosed dPink1 lethality Drosophila level reduction dPink1                   RNAi flies comparable control flies, dropped
expression transgenic RNAi approach complete                          sharply â¬‡40  control level week, level cause lethality.                                                            remained low 2 weeks experimental condition (Fig.
   discernible phenotype dPink1 RNAi flies                     1G). asked energy deficiency affected lifespan
abnormal wing posture: females males exhibited                      dPink1 RNAi flies. global inhibition dPink1
held (Fig. 1D) drooped (Fig. 1E) wing posture,                        reduced lifespan significantly (Fig. 1H Fig. 7, published
control flies held wings parallel body axis (Fig.                 supporting information PNAS web site). Taken 
1C). penetrance phenotype increased age:                        data suggest Pink1 plays important role regulating
raised 29Â°C, â¬‡20  newly eclosed flies exhibited abnormal                        energy metabolism function impact lifespan.
wing posture, 7 days age nearly 100  displayed phenotype. flies problem walking,                    Knocking dPink1 Induced Selective Muscle Degeneration. climbing ability greatly reduced ability fly               possible anatomical basis abnormal wing posture completely abolished 10 days age (Fig. 1F). pheno-                     defective flight muscles. Histological analysis indirect flight
type observed independent dPink1 RNAi lines analyzed.                      muscles (IFMs), major flight muscles, Da-Gal4â¬ŽdPink1
   Considering flight energy-consuming physiolog-                    RNAi flies revealed severe disruption muscle integrity, consistent
ical process relying mitochondrial ATP synthesis hPink1                   finding abolished flight capacity flies (Fig. 2B). reported associated mitochondria,                         Disrupted muscle integrity observed wing elevator
measured energy supply dPink1 RNAi flies, using ATP                     muscles [dorsal ventral muscles (DVMs)] depressor muscles
level index. HPLC data showed dPink1 RNAi flies                        [dorsal longitudinal muscles (DLMs)]. determine 
10794 å…© www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0602493103                                                                                                         Yang et al.
 Fig. 2. Inhibition dPink1 results disrupted IFMs.  H) Light microscopy used examine IFM architecture (stars, dorsal longitudinal muscles; arrows,




                                                                                                                                                                   NEUROSCIENCE
dorsal ventral muscles). Sections resin-embedded thoraces 1-week-old
adult flies stained toluidine blue visualize tissue morphology;
anterior left.  N) Wing posture phenotypes control dPink1 RNAi
flies directed Mhc-Gal4. Fly genotypes Da-Gal4å…¾â«¹  , Da-Gal4â¬ŽUAS-
dPink1 RNAi (B), Mhc-Gal4å…¾â«¹ (C , Mhc-Gal4â¬ŽUAS-dPink1 RNAi (D J),
Mhc-Gal4â¬ŽUAS-dPink1 RNAi; UAS-dPink1 (E K), Mhc-Gal4â¬ŽUAS-dPink1
RNAi; UAS-GFP (F L), Mhc-Gal4â¬ŽUAS-dPink1 RNAi; UAS-hPink1 (G M),             Fig. 3.    Muscle-specific dPink1 RNAi results myopathology age-
Mhc-Gal4â¬ŽUAS-dPink1 RNAi; UAS-hPink1âŒ¬C (H N).                                    dependent apoptosis IFMs.  D) EM analysis IFM ultrastructure                                                                                      flies following genotypes: Mhc-Gal4å…¾â«¹  , Mhc-Gal4â¬ŽUAS-dPink1
                                                                                     RNAi (B), Mhc-Gal4â¬ŽUAS-dPink1 RNAi; UAS-hPink1 (C), Mhc-Gal4â¬ŽUAS-
dPink1 plays direct role flight muscles, directed dPink1                 dPink1 RNAi; UAS- hPink1âŒ¬C (D). Arrows, swollen mitochondria; arrowheads,
RNAi specifically muscle myosin heavy chain                          rod body-like deposits. (E F) EM analysis TTM ultrastructure Mhc-
(Mhc)-Gal4 driver. Despite lower penetrance (â¬‡40  7-day-old                     Gal4å…¾â«¹ (E) Mhc-Gal4â¬ŽUAS-dPink1 RNAi (F) flies. Scale bars (5 â?®m) flies raised 29Â°C), observed similar abnormal wing posture                     shown lower left corner image. (G H) TUNEL staining                                                                                      thoracic musculatures newly eclosed (G) 1-week-old (H) Mhc- muscle disruption flies muscle-specific dPink1
                                                                                     gal4â¬ŽdPink1 RNAi flies. Left, DAPI staining; Center, TUNEL staining; Right,
knockdown (Fig. 2 D J). lower penetrance                            merged images. Arrows point TUNEL-positive nuclei. efficient RNAi Mhc-Gal4 driver contribution nonmuscle cells phenotypes observed ubiquitous RNAi
animals. lines evidence suggested muscle                        length hPink1 hPink1âŒ¬C constructs, making
phenotype resulted specific inhibition dPink1 RNAi.                       hPink1âŒ¬C competent length hPink1 competitive satu-  expression white, DJ-1A, DJ-1B dsRNAs driven                     ration RNAi machinery, did happen. Taken  Gal4 driver effect flight muscles (data                       concluded abnormal wingå…¾muscle phenotype specif-
shown). Second, rescue tissue-specific RNAi pheno-                     ically caused inactivation dPink1.
type increased expression dPink1. reasoned raising level dPink1 transcripts, RNAi effect                    Muscle-Specific dPink1 RNAi Flies Exhibited Mitochondria Dysfunc-
dampened.  coexpression UAS-dPink1 transgene                       tion, DNA Fragmentation, Nemaline-Like Myopathology. suppress abnormal wing disrupted muscle phenotypes                           used transmission electron microscopy investigate induced dPink1 RNAi (Fig. 2 E K). rescuing effect                     nature muscle defects. Wild-type adult IFMs highly
unlikely titration Gal4 protein addition UAS                     regular compact myofibril arrangement, tightly
transgenes, UAS-GFP transgene effect                         packed electron-dense mitochondria interspersed rows phenotypes (Fig. 2 F L). Finally, rescue dPink1                     sarcomeres (Fig. 3A). ubiquitous muscle-specific
RNAi phenotypes coexpression length hPink1                         dPink1 RNAi flies, IFMs showed irregular dispersed
muscle (Fig. 2 G M).  C-terminal truncated form                     myofibril arrangement (Fig. 3B). number mitochondria
hPink1 (hPink1âŒ¬C) able rescue (Fig. 2 H N),                           myofibril reduced, remaining
consistent findings C-terminal truncations hPink1                   mitochondria grossly swollen, lacking electron-dense material, linked familial PD (8, 28). fact used transgenic                  showing disintegration cristae (Fig. 3B). Interestingly, flies expressing comparable levels length hPink1                         electron-dense deposits area IFMs suc-
hPink1âŒ¬C ruled possibility differential rescuing                    cumbed severe disruption (Fig. 3B), reminiscent nemaline
effect differential expression hPink1 (Fig. 8,               (rod body) myopathy humans (29). Notably, abnormally swollen published supporting information PNAS web site).                        mitochondria present morphologically normal myofi-
Instead, result indicates hPink1can functionally substitute                brils (Fig. 3B). Consistent histological observation, myo- dPink1. divergence DNA sequence level                         fibril mitochondrial integrity restored overex-
dPink1 hPink1 makes unlikely hPink1 RNA interfere                   pression length hPink1 (Fig. 3C) hPink1âŒ¬C (Fig. 3D). RNAi efficiency dPink1.  sequence corre-                        contrast IFMs, tergotrochanteral muscles (TTMs), sponding dPink1 dsRNA target sequence wholly present                        â€˜â€˜jumpingâ€™â€™ muscles, remained fairly normal muscle-

Yang et al.                                                                                                PNAS å…© July 11, 2006 å…© vol. 103 å…©  28 å…© 10795
 Fig. 4. Dopaminergic defects dPink1 RNAi flies.  E) mount brain TH immunostaining dorsolateral protocerebral posterior (PPL1) cluster neurons 25-day-old flies following genotypes: TH-Gal4å…¾â«¹  , TH-Gal4å…¾UAS-dPink1 RNAi; UAS-GFP (B), TH-Gal4å…¾UAS-dPink1 RNAi; UAS- hPink1âŒ¬C (C),
TH-Gal4å…¾UAS-dPink1 RNAi; UAS-hPink1 (D), TH-Gal4å…¾UAS-dPink1 RNAi; UAS-hParkin (E). (F) Quantification THâ«¹ neurons individual dopaminergic
clusters adult brains flies indicated genotypes. *, P â¬? 0.01 Studentâ€™s t test. (G) Quantification head dopamine levels TH-Gal4å…¾â«¹,
TH-Gal4å…¾UAS-White RNAi, TH-Gal4å…¾UAS-dPink1RNAi flies, white RNAi flies serving control. *, P â¬? 0.01 Studentâ€™s t test.



specific dPink1 RNAi flies (Fig. 3F, compared Fig. 3E).                number THâ«¹ neurons different dopaminergic clusters differential effects unlikely expression pattern               control dPink1 RNAi flies counted subjected Mhc-GAL4, flies ubiquitous dPink1 RNAi                      statistical analysis. shown Fig. 4B, 25-day-old dPink1 RNAi
normal TTMs. TTMs apparently fewer mitochondria                          flies raised 29Â°C showed significant reduction THâ«¹ neurons IFMs. speculate phenotypic difference                     lateral protocerebral posterior (PPL1) cluster. dorso-
tween IFMs TTMs related different energy                      medial protocerebral posterior (PPM) cluster  known demands.                                                                          dorsomedial cluster (DMC)] showed modest reduction    investigate muscle degeneration dPink1 RNAi flies                neuronal number, clusters relatively unaf-
developed cell death mechanism, IFMs sub-                      fected (Fig. 4F). Importantly, observed muscle, coexpres-
jected terminal deoxynucleotidyltransferase-mediated dUTP                    sion length hPink1, hPink1âŒ¬C, able suppress
nick end labeling (TUNEL) assay. Flies ubiquitous                        dopaminergic phenotype (Fig. 4 C, D, F). Overexpression
continuous induction dPink1 RNAi exhibited extensive TUNEL-                    hPink1 hPink1âŒ¬C effect THâ«¹ neuron number
positive signals IFMs analyzed 4 days age,              (data shown).
age-matched control flies lacked staining (Fig. 9,                     confirm loss dPink1 leads dopaminergic
published supporting information PNAS web site).                     dysfunction, measured brain dopamine levels using head
exclude developmental effect test TUNEL-                       extracts prepared control dPink1 RNAi flies. newly
positive signals induced progressively, muscle-specific                  eclosed flies, dopamine content comparable control
dPink1 RNAi flies subjected temperature-shift protocol                dPink1 RNAi flies (Fig. 4G). flies age, control mentioned earlier. positive TUNEL signal detected IFMs                  dPink1 RNAi flies showed age-dependent decline dopamine flies newly emerged 18Â°C (Fig. 3G).  shifting               levels.  dPink1 RNAi flies consistently exhibited 29Â°C continuously kept temperature 7 days,                     dramatic reduction control (Fig. 4G). Overexpression dPink1 RNAi flies readily showed TUNEL-positive nuclei                    length hPink1, hPink1âŒ¬C, fully restored dopamine level
IFMs (Fig. 3H), treatment effect                      dPink1 RNAi animals (Fig. 10, published supporting
control flies. data suggest muscle-specific dPink1 RNAi                information PNAS web site). Taken  data lead age-dependent muscle degeneration characterized                  suggested dPink1 plays critical role promoting dopami-
extensive DNA fragmentation probably indicative cell death.                    nergic neuronal function survival.

Inactivation dPink1 Dopaminergic Neurons Leads Loss                   Overexpression Parkin Rescued Muscle Dopaminergic
Tyrosine Hydroxylase (TH)â´™ Neuron Reduction Brain Dopamine                 Phenotypes Caused dPink1 Inactivation. noticed similarity
Content. analyzed effects inhibiting dPink1 function               dPink1 RNAi flies parkin mutant flies dopaminergic neurons inducing dPink1 RNAi                          muscle dopaminergic pathology (12, 30, 31). observation
dopaminergic neuron-specific TH-Gal4 driver. presence                      prompted investigate Parkin Pink1 dopaminergic neurons CNS assayed TH immuno-                         involved common physiological processes. Strikingly, abnor-
staining mount preparations adult fly brain.                      mal wing postures caused dPink1 RNAi rescued 
10796 å…© www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0602493103                                                                                                  Yang et al.
 Fig. 5. Genetic biochemical interaction Pink1 Parkin. Wing posture  B), thorax musculature histology (C D), IFM EM images
(E F) Mhc-Gal4å…¾UAS-dPink1 RNAi; UAS-hParkin   C, E), Mhc-Gal4å…¾UAS-dPink1 RNAi; UAS-hDJ-1 (B, D, F) flies shown. Scale bars (2 â?®m) E F shown left corner. (G) body ATP measurements indicated genotypes. *, P â¬? 0.01 Studentâ€™s t test. (H) Western blot
analysis showing reduction dParkin levels dPink1 RNAi animals. Protein extracts prepared Da-Gal4å…¾â«¹ Da-Gal4å…¾UAS-dPink1 RNAi animals 



                                                                                                                                                                NEUROSCIENCE
probed anti-dParkin antibody. Actin serves protein loading control.



overexpression human Parkin (hParkin) (Fig. 5A),                     metabolism. Pink1 function compromised, tissues hDJ-1 (Fig. 5B) dDJ-1A overexpression rescuing effect.                greatest demand energy, presumably IFM Histological EM analyses indicated suppression              dopaminergic neurons, particularly vulnerable. wing phenotype accompanied restoration myofibril                      observation inhibition Pink1 leads ATP depletion integrity mitochondrial morphology (Fig. 5 C E, compared                consistent possibility. second possibility Pink1 Fig. 5 D F).  overexpression hParkin able               normally required guard mitochondrial restore ATP levels dPink1 RNAi flies (Fig. 5G). Importantly,              pathway apoptotic cell death, suggested earlier (27). overexpression hParkin dPink1 RNAi background restored                regard, interesting note Parkin shown number THâ«¹ neurons PPL1 dorsomedial protocere-                    prevent mitochondrial swelling cytochrome c release mito-
bral posterior (PPM1) clusters (Fig. 4 E F).               chondria-dependent cell death (23).  Parkin Pink1 hParkin overexpression showed tendency elevate brain dopa-                 participate common pathway protects cells mito- levels dPink1 RNAi animals, effect statistically            chondria-dependent cell death induced toxic insults. abnor-
significant (Fig. 10).  overexpression hParkin capable            mal mitochondrial morphology associated Parkin Pink1
rescuing   defects caused dPink1 inacti-             inactivation suggests possibility play
vation.                                                                         fundamental roles regulating mitochondrial biogenesis mito-
   gain insight molecular mechanism                chondrial dynamics, mitochondrial fusion fission events.
Parkin overexpression rescues dPink1 RNAi phenotypes, ex-                    connection aberrant mitochondrial fissionå…¾fusion amined Parkin protein level dPink1 RNAi animals. shown                 neurodegeneration appreciated (32). Fig. 5H, Parkin protein level significantly reduced                      studies needed distinguish possibilities.
dPink1RNAi animals compared controls.                                                                                     vivo rescue studies clearly showed C terminus rescue dPink1 RNAi phenotypes Parkin overexpression                                                                                 hPink1 required hPink1 rescue dPink1 RNAi phenotypes.
likely restoration Parkin protein expression                                                                                  C-terminal deleted form Pink1 activity.
                                                                                higher vitro kinase activity terms autophosphorylation (26),
Discussion                                                                      incapable providing spectrum Pink1â€™s biological study, inhibition dPink1 Drosophila leads            activity. possible C-terminal deletion affect mitochondrial abnormality degeneration subsets mus-                binding Pink1 substrates cofactors. Alternatively,
cle fibers dopaminergic neurons. similar phenotypes                     deletion Pink1 C terminus contribute disease pathogen-
caused dPink1 Drosophila Parkin (dParkin) inactivation                   esis causing deregulation Pink1 kinase activity.
prompted investigation genetic biochemical                      vivo biochemical study showed dPink1 RNAi
relationships. overexpression hParkin,                 animals level dParkin significantly reduced. result
DJ-1, rescue muscle dopaminergic pathology                   provides explanation Pink1 Parkin mutants induced dPink1 inactivation. Consistent genetic inter-              similar mutant phenotypes Parkin overexpression action results, level dParkin significantly            rescue dPink1 RNAi phenotypes. supports notion reduced dPink1 RNAi animals.  results strongly                Parkin acts downstream Pink1 common pathway. suggest Parkin Pink1 act common cellular pathway             biochemical mechanism Pink1 regulates Parkin protein
normally promotes function survival select cell types                level requires investigation. summary, mitochondrial
including dopaminergic neurons Parkin act                     pathology IFM dopaminergic neuron degeneration phe-
stream Pink1 pathway.                                                notypes observed dPink1 RNAi animals clear genetic
   molecular mechanism underlying degen-                  interaction Pink1 Parkin suggest genetic
eration phenotypes induced Pink1 dysfunction? lease                 analysis cellular pathway involving Pink1 Parkin possibilities envisioned.  Pink1 regulate energy             reveal fundamental mechanisms governing mitochondrial cel-

Yang et al.                                                                                            PNAS å…© July 11, 2006 å…© vol. 103 å…©  28 å…© 10797
 lular maintenance. mechanisms likely applicable                                           average flies genotype time point mammalian systems.                                                                                        examined, experiment repeated  Muscle
                                                                                                          histology transmission electron microscopy analysis 
Materials Methods                                                                                     formed described (31), Epon resin used Drosophila Genetics. Fly culture crosses performed ac-                                           embedding. TUNEL analysis, adult flies fixed ice-cold
cording standard procedures raised indicated tempera-                                           4  formaldehydeå…¾PBS 3 h. permeation, 1  Triton tures. general fly stocks GAL4 lines obtained                                       prechilled acetone used. Head abdomen Bloomington Drosophila stock center. TH-GAL4 driver                                                                                                           dissected away, thoraces subject TUNEL analysis
gift Serge Birman (Developmental Biology, Institute Marseille, Marseille, France) (33). fly stocks                                             according manufacturerâ€™s instructions (Roche Promega).
described earlier follows: UAS-hParkin (34), UAS-hDJ-1 (21), UAS-White RNAi (35). generate UAS-dPink1 RNAi trans-                                               Flight Longevity Analyses. flight analysis, â¬‡15 flies genics, genomic DNAå…¾cDNA hybrid constructs generated                                              control experimental flies placed individual vials. Flight
described (35), cDNA sequence covered following                                           events counted consecutive minutes late
PCR primers (5â¬˜-TTCTGCCACCACCGCCCCCACACTTC                                                            morning subjected averaging. lifespan analysis, flies
3â¬˜-CCGCAGCACATTGGCAGCGGTGG).                                                                              maintained standard media 29Â°C, 15 flies vial,                                                                                                           transferred new food medium daily. Mortality scored daily.
Molecular Biology. make UAS-hPink1, UAS-hPink1âŒ¬C, UAS-dPink1 transgenics, corresponding cDNAs cloned                                              ATP Dopamine Measurements. fly ATP measure- pUAST vector. plasmid containing hPink1 cDNA gift                                           ment, live adult flies dropped liquid nitrogen snap M. Unoki (36). hPink1âŒ¬C construct contains 509                                         freezing. microliters dry ice-embedded acetonitrile aa, mimicking reported disease-linked, C-terminal truncated                                           added flies, homogenized adding ice-cold
form hPink1 (28). Details cloning steps available                                                                                                           deionized H2O. homogenate centrifuged 13,200 â«» g request. RT-PCR analysis, 4-day-old adult flies cross UAS-dPink1 RNAi Da-GAL4 raised 29Â°C used                                              4Â°C 15 min, 50 â?®l supernatant mixed 50 â?®l prepare total RNA using RNeasy Kit (Qiagen). Details                                          deionized H2O, centrifuged  readied HPLC assay. quantitative RT-PCR procedure essentially described                                           HPLC analysis ATP content performed essentially (34). Antibody dPINK1 elicited rabbits recom-                                         described (37, 38). HPLC analysis catecholamine levels binant proteins purified bacteria culture expressing pGEX-                                           performed described (39, 40). sample preparation, adult
6P-1-Pink1C, contains C-terminal 97 aa dPink1 (amino                                         male fly heads dissected homogenized 0.1 M
acids 624 721). Western blot analysis using antibody                                       perchloric acid (generally 50 â?®l heads) using performed described (34), primary antibody used                                            motorized hand-held tissue grinder. homogenate frozen
1:1,000 dilution. hParkin cDNA, gift N. Hattori (Juntendo                                          immediately dry ice stored â«º80Â°C HPLC analysis.
University, Tokyo, Japan), inserted pcDNA3 vector Myc tag C terminus. Rabbit anti-Drosophila TH antibody                                             thank Dr. Serge Birman Bloomington Drosophila Stock
raised recombinant GST-Drosophila TH (longer isoform,                                             Center fly stocks, Dr. M. Unoki hPink1 cDNA, Dr. N. Hattori
1â€“328 aa) produced bacteria. crude serum immunoab-                                             hParkin cDNA, Dr. Leo Palanck dParkin antibody, Dr. Su Guo
sorbed NHS-activated Sepharose (General Electric Bio-                                                reading manuscripts, Dr. Zhuohua Zhang communicating
sciences) coupled soluble bacteria proteins. Supernatant                                             unpublished results. thank Jennifer Quach Yali Zhang (1:500) used immunostaining.                                                                  excellent technical support members Lu laboratory                                                                                                           discussions. work supported McKnight, Beckman, Histology Immunohistochemistry, Muscle Histology, Trans-                                          Sloan Foundations (B.L.), Naito Foundation Japan Society mission Electron Microscopy Analysis. mount immunohisto-                                            Promotion Science Postdoctoral Fellowships Research Abroad  chemistry TH staining performed described (31).                                             Y ), Stanford Bio X Graduate Fellowship  Y.Y.).


 1.   Dunnett, S. B. & Bjorklund,  (1999) Nature 399, A32â€“A39.                                          21. Yang, Y., Gehrke, S., Haque, M. E., Imai, Y., Kosek, J., Yang, L., Beal, M. F., Nishimura,
 2.   Dawson, T. M. & Dawson, V. L. (2003) Science 302, 819â€“822.                                              , Wakamatsu, K., Ito, S., et al. (2005) Proc. Natl. Acad. Sci. USA 102, 13670â€“13675.
 3.   Bertoli-Avella,  M., Oostra, B.  & Heutink, P. (2004) Hum. Genet. 114, 413â€“438.                 22. Zhang, L., Shimoji, M., Thomas, B., Moore, D. J., Yu, S. W., Marupudi, N. , Torp, R.,
 4.   Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, , Dutra, , Pike, B.,            Torgner,  , Ottersen, O. P., Dawson, T. M. & Dawson, V. L. (2005) Hum. Mol. Genet.
      Root, H., Rubenstein, J., Boyer, R., et al. (1997) Science 276, 2045â€“2047.                              14, 2063â€“2073.
 5.   Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S.,                   23. Darios, F., Corti, O., Lucking, C. B., Hampe, C., Muriel, M. P., Abbas, N., Gu, W. J., Hirsch,
      Yokochi, M., Mizuno, Y. & Shimizu, N. (1998) Nature 392, 605â€“608.                                       E. C., Rooney, T., Ruberg, M. & Brice,  (2003) Hum. Mol. Genet. 12, 517â€“526.
 6.   Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein,           24. Elkon, H., Don, J., Melamed, E., Ziv, , Shirvan,  & Offen, D. (2002) J. Mol. Neurosci. 18, 229â€“238.
      M. J., Jonnalagada, S., Chernova, T., et al. (1998) Nature 395, 451â€“452.                            25. Beilina, , Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D. W., Petsko, G.  &
 7.   Bonifati, V., Rizzu, P., Squitieri, F., Krieger, E., Vanacore, N., van Swieten, J. C., Brice, ,       Cookson, M. R. (2005) Proc. Natl. Acad. Sci. USA 102, 5703â€“5708.
      van Duijn, C. M., Oostra, B., Meco, G. & Heutink, P. (2003) Neurol. Sci. 24, 159â€“160.               26. Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M. &
 8.   Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M., Harvey, K., Gispert, S., Ali,            Casari, G. (2005) Hum. Mol. Genet. 14, 3477â€“3492.
      , Del Turco, D., Bentivoglio,  R., Healy, D. G., et al. (2004) Science 304, 1158â€“1160.          27. Petit, , Kawarai, T., Paitel, E., Sanjo, N., Maj, M., Scheid, M., Chen, F., Gu, Y., Hasegawa,
 9.   Zimprich, , Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J.,            H., Salehi-Rad, S., et al. (2005) J. Biol. Chem. 280, 34025â€“34032.
      Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) Neuron 44, 601â€“607.
                                                                                                          28. Rohe, C. F., Montagna, P., Breedveld, G., Cortelli, P., Oostra, B.  & Bonifati, V. (2004)
10.   Paisan-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simon, J., van der Brug, M., Munain,
                                                                                                              Ann. Neurol. 56, 427â€“431.
       L., Aparicio, S., Gil,  M., Khan, N., et al. (2004) Neuron 44, 595â€“600.
                                                                                                          29. Wallgren-Pettersson, C. (2002) Semin. Pediatr. Neurol. 9, 132â€“144.
11.   Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Klose, J. & Shen, J. (2004)
                                                                                                          30. Whitworth,  J., Theodore, D. , Greene, J. C., Benes, H., Wes, P. D. & Pallanck, L. J.
      J. Biol. Chem. 279, 18614â€“18622.
                                                                                                              (2005) Proc. Natl. Acad. Sci. USA 102, 8024â€“8029.
12.   Greene, J. C., Whitworth,  J., Kuo, , Andrews, L. , Feany, M. B. & Pallanck, L. J. (2003)
      Proc. Natl. Acad. Sci. USA 100, 4078â€“4083.                                                          31. Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M.,
13.   Hsu, L. J., Sagara, Y., Arroyo, , Rockenstein, E., Sisk, , Mallory, M., Wong, J.,                   Bellen, H. & Mardon, G. (2004) Development (Cambridge, U.K.) 131, 2183â€“2194.
      Takenouchi, T., Hashimoto, M. & Masliah, E. (2000)  J. Pathol. 157, 401â€“410.                     32. Bossy-Wetzel, E., Barsoum, M. J., Godzik, , Schwarzenbacher, R. & Lipton, S.  (2003)
14.   Hyun, D. H., Lee, M., Hattori, N., Kubo, S., Mizuno, Y., Halliwell, B. & Jenner, P. (2002)              Curr. Opin. Cell Biol. 15, 706â€“716.
      J. Biol. Chem. 277, 28572â€“28577.                                                                    33. Friggi-Grelin, F., Coulom, H., Meller, M., Gomez, D., Hirsh, J. & Birman, S. (2003)
15.   Orth, M., Tabrizi, S. J., Schapira,  H. & Cooper, J. M. (2003) Neurosci. Lett. 351, 29â€“32.            J. Neurobiol. 54, 618â€“627.
16.   Sherer, T. B., Betarbet, R., Stout,  K., Lund, S., Baptista, M., Panov,  V., Cookson, M. R.     34. Yang, Y., Nishimura, , Imai, Y., Takahashi, R. & Lu, B. (2003) Neuron 37, 911â€“924.
      & Greenamyre, J. T. (2002) J. Neurosci. 22, 7006â€“7015.             